Bilateral Neuralgic Amyotrophy Presenting with Left Vocal Cord and Phrenic Nerve Paralysis  by Chen, Yi-Min et al.
680 J Formos Med Assoc | 2007 • Vol 106 • No 8
CASE REPORT
Bilateral Neuralgic Amyotrophy Presenting
with Left Vocal Cord and Phrenic 
Nerve Paralysis
Yi-Min Chen,1* Gwo-Chi Hu,2 Sho-Jen Cheng,3
This article reports the difference between neuralgic amyotrophy and neuropathy caused by chemotherapy
and radiation treatment which manifested with severe shoulder pain followed by marked weakness of bi-
lateral upper arms and involvement of cranial nerves. A 62-year-old man presented with acute severe neu-
ropathic pain at the left shoulder, bilateral shoulder weakness, hoarseness of voice from vocal cord palsy,
and respiratory insufficiency from left diaphragm palsy, which all occurred sequentially over a 1-month
period. The diagnosis of neuralgic amyotrophy was supported and differentiated from tumor-induced and
radiation-induced neuropathy by clinical presentation, electrophysiologic and imaging studies. Unlike previ-
ous reports of the onset of neuralgic amyotrophy being associated with initiation of radiation treatment in
cancer patients, this report demonstrates that neuralgic amyotrophy can occur at any point of the malignant
disease process after radiation and chemotherapy. [J Formos Med Assoc 2007;106(8):680–684]
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Neuralgic amyotrophy is an uncommon neurolo-
gic syndrome that was first described by Parsonage
and Turner in 1948. The incidence has been esti-
mated at approximately 1.64 in 100,000. It is com-
mon between the third and sixth decades of life
and has a slight male preponderance. It is charac-
terized by acute onset of neuropathic pain followed
by sensory loss, weakness and atrophy of mus-
cles with the involved nerves showing multifocal
inflammation.1,2 Despite its classical presentation
in the brachial plexus, it has recently been recog-
nized to affect all the peripheral nerves elsewhere,
singly or in combination, producing diverse clin-
ical syndromes.3–7 Sanders et al8 and Pierre et al5
reported the association of neuralgic amyotrophy
with cranial nerve involvement. Although the exact
pathogenesis remains unknown, an immunologic
factor has been postulated to play a role.9 Most
patients recover from pain and weakness slowly
over months or years and can be treated symp-
tomatically with steroid, analgesic and physical
therapy.
Case Report
A 62-year-old man with a 5-year history of naso-
pharyngeal cancer awoke from sleep at night with
a sudden sharp pain and numbness over the left
shoulder girdle. The pain increased in intensity
and spread to the lateral side of his arm and neck
over the next 24 hours. Three hours after the onset
of pain, he felt progressive weakness of his left
shoulder girdle muscles that spread to the left
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upper limb, right shoulder girdle and right upper
limb a day later. He noticed hoarseness 3 days
later. Resting dyspnea and orthopnea ensued 
4 weeks later. There was no preceding viral illness,
recent vaccination, strenuous activities, surgery,
trauma or family history of hereditary neuralgic
amyotrophy. His nasopharyngeal cancer was diag-
nosed 5 years earlier at the age of 57 and he had
received radiation treatment (totaling 70 Gy) com-
bined with cisplatin chemotherapy at a dose of
20 mg/m2/day and 5-fluorouracil 1000 mg/m2/
day for 5 days every 4 weeks for 2 cycles during
radiation treatment and 4 cycles after radiation.
Yearly follow-up did not show any recurrence of
nasopharyngeal cancer.
On neurologic examination, severe weakness
and atrophy (Medical Research Council [MRC]
grade 0–1) in the supraspinatus and infraspinatus,
moderate (MRC grade 2) weakness in the deltoid,
and mild weakness (MRC grade 3) in the biceps
brachii and brachioradialis of both upper limbs
were noted. There was no weakness in the mus-
cles of the lower limbs. Except for the absent deep
tendon reflexes in bilateral biceps, the reflexes in
all limbs were normal. Sensory examination re-
vealed decreased sensation in the distribution of
the left axillary nerve.
Laboratory workup including complete blood
count, kidney, liver and thyroid functions, elec-
trolytes, creatinine kinase, antinuclear antibody,
rheumatoid factor, erythrocyte sedimentation rate,
and cerebrospinal fluid were all normal (protein,
25 mg/dL; glucose, 75 mg/dL; red blood cell,
1/mm3; white blood cell, 0/mm3; negative Pandy
test). Serology for cytomegalovirus and Epstein–
Barr virus was negative.
Nerve conduction velocity (NCV) studies of
the upper and lower limbs revealed mild sensori-
motor type of polyneuropathy superimposed with
decreased sensory nerve action potentials in bi-
lateral lateral antebrachial cutaneous and radial
nerves with decreased amplitudes of bilateral ax-
illary and musculocutaneous nerves (Tables 1 and
2). Needle electromyography study of the affected
muscles showed no myokymic discharges, but
spontaneous activities like fibrillation potentials
and positive sharp waves were noted in bilateral
biceps and deltoid with polyphasic motor unit
potentials in bilateral supraspinatus and infra-
spinatus, deltoid and biceps muscles. Cervical
paraspinal muscles were normal.
Laryngoscopy showed left vocal cord paralysis
in the paramedian position (Figure 1). Cervical
magnetic stimulation of the phrenic nerve showed
Table 1. Motor nerve study 
Nerve Stimulation site Distance (cm) Latency (ms) Amplitude (mV) Velocity (m/s)
Left median Wrist 8 4.00 8.3
Elbow 17 7.20 8.1 53.1
Right median Wrist 8 4.45 9.1
Elbow 19.5 8.10 9.1 53.4
Left ulnar Wrist 8 2.85 10.5
Elbow 30.5 8.10 10.0 58.1
Right ulnar Wrist 8 2.75 10.8
Elbow 28.5 8.00 10.6 54.3
Left radial Elbow 15 4.45 7.5
Erb’s point 29 8.85 1.0 65.9
Right radial Elbow 16 4.70 7.5
Erb’s point 30 9.20 1.5 66.7
Right axillary Erb’s point 20 5.55 0.4
Left axillary Erb’s point 21 5.45 0.2
Right musculocutaneous Erb’s point 33 6.55 0.5
Left musculocutaneous Erb’s point 31.5 7.70 0.3
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absent response from the left diaphragm. Elevation
of the left hemidiaphragm was noted on chest
radiography and computed tomography (Figure
2) taken at the onset of dyspnea and was confirmed
by chest ultrasonography. Electrocardiography and
laboratory tests ruled out cardiac and pulmonary
causes of his dyspnea. Pulmonary function tests
were normal.
Magnetic resonance imaging study showed
normal brachial plexus without abnormal en-
hancement, but there was post-radiation change
involving the upper cervical spine with circum-
ferential disc bulging at C5–6 and C6–7 without
any nerve compression and no tumor recurrence
in the ear, nose and throat. Whole body bone scan
(99mTc-methylene diphosphonate) and positron
emission tomography scan (fluorine-18-fluoro-
2-deoxyglucose) could not identify recurrent
metastasis.
The patient was treated conservatively, with
steroid, analgesic and physical therapy for weak-
ness, and β-agonist and steroid for dyspnea. His
pain disappeared after 1 week and his dyspnea
and hoarseness of voice resolved slowly over 
2 months. However, weakness of bilateral upper
Table 2. Sensory nerve study
Nerve Recording site Distance (cm) Latency (ms) Amplitude (mV) Velocity (m/s)
Left medial ante-cut Forearm 17 2.65 13.6 64.2
Right medial ante-cut Forearm 14.5 2.15 15.1 67.4
Left lateral ante-cut Forearm NP
Right lateral ante-cut Forearm 12 1.80 3.6 66.7
Left median Digit III 17.5 3.10 8.7 56.5
Right median Digit III 18 3.15 9.7 57.1
Left ulnar Digit V 15 2.75 8.1 54.5
Right ulnar Digit V 15 2.75 7.8 54.5
Left radial Thumb 13 2.40 1.6 54.2
Right radial Thumb 13 2.20 4.2 59.1
Left sural Lat malleolus 13 3.15 17.5 41.3
ante-cut = antebrachial cutaneous; NP = not performed.
Figure 1. Laryngoscopy reveals the left vocal cord to be
immobilized in the paramedian position.
Figure 2. Computed tomography of the chest reveals ele-
vation of the left diaphragm.
shoulders persisted (Figure 3) as manifested by
MRC grade 2 in the supraspinatus and infra-
spinatus, and MRC grade 3 in the deltoid, biceps
brachii and brachioradialis. Follow-up NCV study
did not show any significant change.
Discussion
Neuralgic amyotrophy has been reported to pres-
ent with sudden onset of neuropathic pain, usually
at night,10 in bilateral shoulder and arm areas
followed within hours and weeks by paresis or
paralysis of muscle groups innervated by the af-
fected nerves, nerve roots or plexi.11,12 There are
articles reporting the link between neuralgic amy-
otrophy with recurrent laryngeal nerve palsy;7,8
neuralgic amyotrophy should be suspected in un-
explained acute neuropathic pain in the shoulders
and upper limbs or unexplained diaphragmatic
palsy with respiratory insufficiency. Recently, ad-
vanced imaging studies, such as magnetic reso-
nance neurography, have contributed significantly
to the evaluation of brachial plexopathy.13
Nerves can be damaged by radiotherapy de-
pending on the total or fractional dose of radiation
as well as the premorbid state of the irradiated
nerve.14 Radiation-induced neuropathy presents
in three distinct clinical syndromes: classic delayed
injury from fibrosis,15 transient or reversible is-
chemic injury,16 and acute ischemic injury.17 It
usually results from radiation to the neck or axil-
lary regions, as commonly seen in breast cancer
and lymphoma patients.18 Unlike the clinical
manifestations of neuralgic amyotrophy, delayed
radiation-induced neuropathy has slow progres-
sive onset of sensory loss and paresthesia, mild or
no pain, muscle weakness and atrophy, and long
duration (months or years) of muscle weakness
and disability.18 Neuralgic amyotrophy has been
reported to occur within days to 2 months after
initiation of radiation in patients with Hodgkin’s
disease.19 Gorkhaly and Lo described a case of
radiation-induced brachial plexopathy in naso-
pharyngeal cancer.20
Chemotherapy is known to significantly in-
crease the incidence of neuropathy by a magnitude
of two folds or more. Concomitant chemother-
apy with radiation treatment has become the
treatment of choice for advanced head and neck
cancers. Cisplatin, paclitaxel, suramin and vin-
cristine commonly cause neuropathy.21,22 Barbieux
et al reported a case of neurotoxicity induced 
by 5-fluorouracil.23 Cisplatin-induced peripheral
neuropathy is characterized mainly by sensory
deficit, with occasional motor disturbance and
decreased deep tendon reflexes. Though the symp-
toms of neuropathy may begin 3–8 weeks after
the last dose of cisplatin, they commonly occur
during the chemotherapy cycles. Chemotherapy-
induced neuropathy can also present subclini-
cally with abnormalities in study reports but no
clinical features.24,25
In cancer patients with radiation treatment,
distinguishing neuropathy induced by cancer, ra-
diation and neuralgic amyotrophy is important
for choosing treatment modalities.19,26 History and
clinical presentation are the most useful. Though
it is a challenge to distinguish between neuralgic
amyotrophy and radiation-induced neuropathy
by imaging, tumor mass can be found by ad-
vanced imaging alone.27 Myokymic changes can be
found on electromyography in radiation-induced
neuropathy.
The clinical picture and evidence reported here
with this nasopharyngeal cancer patient 5 years
after radiation and chemotherapy clearly favor
neuralgic amyotrophy rather than delayed onset
radiation-induced brachial plexopathy or cancer
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Figure 3. Atrophic shoulder.
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recurrence. It is noteworthy that the onset of neu-
ralgic amyotrophy might not have a temporal re-
lationship to radiation treatment in cancer patients
treated with both radiation and chemotherapy.
Although the exact mechanism of delayed neu-
ralgic amyotrophy in this case remains unknown,
nerves damaged subclinically by radiation and/or
chemotherapy are predisposed to develop neural-
gic amyotrophy at any time after the treatments.
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